Welcome to the Illinois Medical Oncology Society

Illinois Medical Oncology Society (IMOS)

Formed on July 29, 1989, the Illinois Medical Oncology Society (IMOS) represents the common interests of a majority of the oncologists treating cancer in Illinois. As the oncology society in Illinois, we strive to provide our members with innovative resources to help them stay ahead of the shifting healthcare landscape and challenges that directly impact the high-quality care their patients deserve.

The Illinois Medical Oncology Society now offers FREE  memberships to oncologists and allied oncology professionals.

 

Find out more about membership

 

The IMOS board would also like to hear from you (all levels and types of members and potential members) about things you’d like to see for 2018- 2019 and how we can best serve your needs.

 

We are a State Affiliate of the American Society of Clinical Oncology.

Our Mission

We strive to promote the highest professional standards of oncology in the State of Illinois.  We create educational experiences for our members to exchange information to increase the quality of care for our patients. We act as a patient advocate to assure that patients have access to the best available care; and support and encourage clinical research against cancer.

Find out more

CDC Issues Key Clarification on Guideline for Prescribing Opioids for Chronic Pain
Agency Clarifies CDC Guideline Not Meant to Limit Access to Appropriate Pain Management for Individuals with Cancer, Sickle Cell Disease

Click here for more.

CMS Releases Final Hospital Outpatient Payment Rule - The Centers for Medicare and Medicaid Services (CMS) released the final CY 2019 Hospital Outpatient Prospective Payment System (OPPS) rule. In the Society’s comment letter, ASH requested that CMS change the status indicator for the four new Category III CPT codes for chimeric antigen receptor (CAR) T-cell therapy from “B” to “S.” In the final rule, CMS did finalize this change for one of the four codes, code 0540T, CAR-T cell administration, autologous. 

Click here for the report.

CMS Open Payments: Review and Dispute Period Now Open

U.S. physicians have from April 1 until May 15 to review and dispute Open Payments data before it is made public on June 30. Review of the data is voluntary, but strongly encouraged to help improve the accuracy of the reported data.

Learn More Here.

News

IMOS Spring Meeting

May 9-10, 2019
Westin, 909 N. Michigan Avenue

Click here for more

Save the Date for the IMOS Fall Meeting

September 13 - 14, 2019
Lincolnshire Marriott Resort
Ten Marriott Drive · Lincolnshire, Illinois 60069 USA
1-847-634-0100

Click here to make your hotel reservations online*
*Make sure to mention the IMOS Fall meeting to get your conference rate.

Denial Rates and Days to Pay for Cancer Drugs: Commercial Health Plan Report Card

Office-administered oncology drugs given in the community setting face stiff reimbursement challenges when billing commercial plans; while Medicare has emerged as the gold standard for both predictable payment and timeliness. 

Click here for More.

 

Learn more about the big changes to the ASH Scholar Award program.
More people are now eligible for the ASH Scholar Awards than ever before. The new Fellow to Faculty Scholar Award offers financial support to those preparing to compete for independent faculty-level positions in the next two to three years.

Click here for more.